QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Background: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). Objective: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Arun R. Sridhar, MBBS, MPH, Neal A. Chatterjee, MD, MSc, Basil Saour, MD, Dan Nguyen, MD, Elizabeth A. Starnes, ARNP, Christine Johnston, MD, MPH, Margaret L. Green, MD, MPH, Gregory A. Roth, MD, Jeanne E. Poole, MD, FHRS
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Elsevier 2020-08-01
Loạt:Heart Rhythm O2
Những chủ đề:
Coronavirus
Electrocardiogram
Hydroxychloroquine
QT interval
Ventricular arrhythmia
Truy cập trực tuyến:http://www.sciencedirect.com/science/article/pii/S2666501820300751

Internet

http://www.sciencedirect.com/science/article/pii/S2666501820300751

Những quyển sách tương tự